Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma of the Lungs”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT00852644
What this trial is testing

Stereotactic Radiosurgery in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Boston Medical Center 9
Not applicableStudy completedNCT05815407
What this trial is testing

Expressiona and Diagnostic Potential of miRNAs in NSCLC

Who this might be right for
Non Small Cell Lung Cancer
Al-Azhar University 100
Not applicableStudy completedNCT04490564
What this trial is testing

Validation of Molecular Diagnostic Assays to Detect Cancer Biomarkers in Blood and Primary Tumor in HNSCC/NSCLC/Melanoma

Who this might be right for
Head and Neck Squamous Cell CarcinomaNon Small Cell Lung CancerMelanoma
Pharmassist Ltd 135
Testing effectiveness (Phase 2)Study completedNCT03693612
What this trial is testing

GSK3359609 Plus Tremelimumab for the Treatment of Advanced Solid Tumors

Who this might be right for
Neoplasms
GlaxoSmithKline 26
Testing effectiveness (Phase 2)Ended earlyNCT00537511
What this trial is testing

A Phase I/II Study to Determine the Maximum Tolerated Dose (MTD) and Safety of CC-4047 (Pomalidomide) Administered in Conjunction With Cisplatin and Etoposide

Who this might be right for
Carcinoma, Small Cell
Celgene 22
Testing effectiveness (Phase 2)Looking for participantsNCT06244771
What this trial is testing

A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors

Who this might be right for
Advanced Solid Tumors With KRAS G12C MutationsSolid Tumor, AdultUnresectable Solid Tumor+5 more
Frontier Medicines Corporation 403
Testing effectiveness (Phase 2)Ended earlyNCT02669914
What this trial is testing

MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors

Who this might be right for
Non-Small Cell Lung CancerNonsmall Cell Lung CancerBreast Cancer+15 more
Washington University School of Medicine 4
Early research (Phase 1)Ended earlyNCT05443971
What this trial is testing

Durvalumab and Grid Therapy for Non-small Cell Lung Cancer in Progression During or After Treatment With PACIFIC Regimen

Who this might be right for
Lung Non-Small Cell CarcinomaStage III Lung Cancer AJCC v8
Mayo Clinic 4
Large-scale testing (Phase 3)UnknownNCT02029209
What this trial is testing

To Predict Efficacy by Detecting Circulating Endothelial Cell Subsets and Blood Perfusion Parameters Changes in Vivo Tumor in the Phase II/III Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 110
Not applicableEnded earlyNCT01946100
What this trial is testing

Treatment of Multifocal Lung Adenocarcinoma

Who this might be right for
Lung NeoplasmsCarcinoma Non-small-cell LungAdenocarcinoma
Mayo Clinic 100
Large-scale testing (Phase 3)Active Not RecruitingNCT01933932
What this trial is testing

Assess Efficacy & Safety of Selumetinib in Combination With Docetaxel in Patients Receiving 2nd Line Treatment for v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Positive NSCLC

Who this might be right for
Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV
AstraZeneca 510
Not applicableStudy completedNCT01261598
What this trial is testing

Predictive Value of FDG-TEP During Radiotherapy or Chemo-radiotherapy in Patients With NCSC on the One-year Survival

Who this might be right for
Lung CancerNSCLC
Centre Henri Becquerel 98
Not applicableLooking for participantsNCT07224464
What this trial is testing

The Sarah Nanotechnology System for Treatment of Advanced Metastatic Solid Tumors Using Hyperthermia.

Who this might be right for
Metastatic Solid TumorsStage 4 Cancer
New Phase Ltd. 12
Early research (Phase 1)Active Not RecruitingNCT05195619
What this trial is testing

Personalized DC Vaccines in Non Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Centre Hospitalier Universitaire Vaudois 16
Not applicableStudy completedNCT03427567
What this trial is testing

Evaluate Effectiveness of Sublobar Dissection in Patients With Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Tongji Hospital 3,902
Not applicableStudy completedNCT03132493
What this trial is testing

Nivolumab in the Real World: Analysis of the Expanded Use in Spanish Patient

Who this might be right for
Non Small Cell Lung Cancer
Spanish Lung Cancer Group 676
Early research (Phase 1)Study completedNCT00456833
What this trial is testing

Combination of RAD001 and Erlotinib in Patients With Advanced Non Small Cell Lung Cancer Previously Treated Only With Chemotherapy

Who this might be right for
Non Small Cell Lung Cancer
Novartis Pharmaceuticals 248
Early research (Phase 1)Study completedNCT01703481
What this trial is testing

Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 in Adult Participants With Advanced or Refractory Solid Tumors or Lymphoma

Who this might be right for
Tumor or Lymphoma
Janssen Research & Development, LLC 188
Not applicableStudy completedNCT02658747
What this trial is testing

Neutropenic Sepsis in Patients With Non-Small Cell Lung Cancer Treated With Single-Agent Docetaxel and Associated Resource Use in the UK

Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 120
Testing effectiveness (Phase 2)Ended earlyNCT01217411
What this trial is testing

RO4929097 and Whole-Brain Radiation Therapy or Stereotactic Radiosurgery in Treating Patients With Brain Metastases From Breast Cancer

Who this might be right for
Adult Solid NeoplasmExtensive Stage Lung Small Cell CarcinomaHER2/Neu Negative+10 more
National Cancer Institute (NCI) 5
Next Page